To Be Discontinued Tablet Cardiovascular

Pravastatin Sodium Tablet · 8 active FDA presentation rows for this drug

Brand: PRAVASTATIN SODIUM

FDA lists Pravastatin Sodium Tablet as To Be Discontinued (Teva Pharmaceuticals USA, Inc.).

No availability text on this FDA row.

Pravastatin Sodium Tablet: To Be Discontinued

FDA availability text is not recorded on this row. 8 shortage presentations are tracked for this drug. Contact your pharmacist if you are affected.

Shortage Details

Generic Name
Pravastatin Sodium Tablet
Manufacturer
Teva Pharmaceuticals USA, Inc.
Dosage Form
Tablet
Presentation
Pravastatin Sodium, Tablet, 80 mg (NDC 0480-7270-10)
Package NDC
0480-7270-10

Status & Timeline

Status
To Be Discontinued
First Reported
Jun 13, 2025
Last Updated
Jun 13, 2025
Therapeutic Category
Cardiovascular

Row fields from the FDA Drug Shortages database via openFDA.

Full Drug Profile

pravastatin

Side effects, interactions, warnings & more

View Profile
Compare pravastatin with alternatives →

Nearby, Other Pravastatin Shortage Records

Pravastatin Sodium Tablet

Teva Pharmaceuticals USA, Inc.

Tablet

To Be Discontinued

Pravastatin Sodium Tablet

Teva Pharmaceuticals USA, Inc.

Tablet

To Be Discontinued

Pravastatin Sodium Tablet

Teva Pharmaceuticals USA, Inc.

Tablet

To Be Discontinued

Pravastatin Sodium Tablet

Teva Pharmaceuticals USA, Inc.

Tablet

To Be Discontinued

Pravastatin Sodium Tablet

Teva Pharmaceuticals USA, Inc.

Tablet

To Be Discontinued

Pravastatin Sodium Tablet

Teva Pharmaceuticals USA, Inc.

Tablet

To Be Discontinued
← All Drug Shortages